Wharton J, Polak J M, Gordon L, Banner N R, Springall D R, Rose M, Khagani A, Wallwork J, Yacoub M H
Transplant Unit, Papworth Hospital, Cambridge, U.K.
Circ Res. 1990 Apr;66(4):900-12. doi: 10.1161/01.res.66.4.900.
Knowledge about the distribution and origins of peptide-containing nerves in the innervated and transplanted heart is lacking. Immunohistochemical and histochemical techniques were used to visualize human cardiac innervation before and after transplantation. In the recipient heart cardiac nerve fibers and fascicles displayed immunoreactivity for general neural (protein gene product 9.5 and synaptophysin) and Schwann cell markers (S-100). A major proportion of cardiac nerves displayed neuropeptide tyrosine and tyrosine hydroxylase immunofluorescence staining. Subpopulations of nerves contained somatostatin, vasoactive intestinal polypeptide, calcitonin gene-related peptide, substance P- or neurokinin-like immunoreactivity, and acetylcholinesterase activity. Tissues from cardiac allografts (5 weeks to 63 months after transplantation) contained nerves and ganglion cells that were acetylcholinesterase positive and immunoreactive for the general neural markers. These nerves were less numerous than in recipient hearts and rarely displayed neuropeptide immunostaining. Atrial natriuretic peptide immunoreactivity was localized to myocardial cells in transplanted hearts as well as explanted recipient and postmortem hearts. While most human cardiac allografts remain functionally extrinsically denervated, they appear to contain viable intrinsic nerves, and myocardial cells retain the capacity to produce atrial natriuretic peptide.
目前尚缺乏关于含肽神经在受支配和移植心脏中的分布及起源的知识。采用免疫组织化学和组织化学技术来观察移植前后的人类心脏神经支配情况。在受体心脏中,心脏神经纤维和神经束对一般神经标记物(蛋白基因产物9.5和突触素)以及施万细胞标记物(S-100)呈免疫反应性。大部分心脏神经呈现神经肽Y和酪氨酸羟化酶免疫荧光染色。神经亚群含有生长抑素、血管活性肠肽、降钙素基因相关肽、P物质或神经激肽样免疫反应性以及乙酰胆碱酯酶活性。心脏同种异体移植组织(移植后5周 至63个月)含有对乙酰胆碱酯酶呈阳性反应且对一般神经标记物呈免疫反应性的神经和神经节细胞。这些神经比受体心脏中的数量少,且很少呈现神经肽免疫染色。心房利钠肽免疫反应性定位于移植心脏以及取出的受体心脏和尸检心脏的心肌细胞中。虽然大多数人类心脏同种异体移植在功能上仍为外在去神经支配,但它们似乎含有存活的内在神经,并且心肌细胞保留了产生心房利钠肽的能力。